ALPS Advisors’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-44,562
Closed -$233K 1021
2024
Q3
$233K Sell
44,562
-3,701
-8% -$19.4K ﹤0.01% 973
2024
Q2
$215K Buy
48,263
+4,703
+11% +$21K ﹤0.01% 948
2024
Q1
$334K Buy
43,560
+1,345
+3% +$10.3K ﹤0.01% 878
2023
Q4
$180K Buy
+42,215
New +$180K ﹤0.01% 945